Synopsis
Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
Australia
0
South Africa
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Amatine
2. Gutron
3. Midodrin
4. Midodrine
5. Midodrine Monohydrochloride
6. Midon
7. Monohydrochloride, Midodrine
8. Proamatine
9. St 1085
10. St-1085
11. St1085
1. 3092-17-9
2. 43218-56-0
3. Pro-amatine
4. Midodrine Hcl
5. Amatine
6. Hipertan
7. Gutron
8. Proamatine
9. Midodrine (hydrochloride)
10. St. Peter 224
11. (+-)-midodrine Hydrochloride
12. Metligine
13. Midodrine Monohydrochloride
14. A-4020 Linz
15. 2-amino-n-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide Monohydrochloride
16. (+/-)-midodrin
17. Nsc-758429
18. 59jv96ytxv
19. St-peter-224
20. St 1085 [as The Base]
21. St1085 Hydrochloride
22. (+/-)-midodrine Hydrochlorid
23. St-1085 Base
24. St-1085 Hydrochloride
25. Chebi:31847
26. (+-)-1-(2',5'-dimethoxyphenyl)-2-glycinamidoethanol Hydrochloride
27. 2-amino-n-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide;hydrochloride
28. (+-)-2-amino-n-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide Monohydrochloride
29. Metligene
30. Midamine
31. 2-amino-n-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide Hydrochloride
32. Dsstox_cid_27493
33. Dsstox_rid_82380
34. Dsstox_gsid_47493
35. 2-amino-n-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)acetamide Monohydrochloride
36. Rac-n-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]glycinamide Hydrochloride
37. A 4020 Linz
38. Acetamide, 2-amino-n-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]-, Hydrochloride (1:1)
39. Smr000058833
40. Midodrine Hydrochloride [usan]
41. Einecs 256-148-3
42. Ts 701
43. Unii-59jv96ytxv
44. (+-)-midodrin Hydrochloride
45. 2-amino-n-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)acetamide Hydrochloride
46. Prestwick_625
47. Pro-amatine (tn)
48. Midodrine Hydrochloride [usan:usp:jan]
49. Midodrine, Hydrochloride
50. 1-(2',5'-dimethoxyphenyl)-2-glycinamidoethanol Hydrochloride
51. Ncgc00016620-01
52. 2-amino-n-(2-(2,5-dimethoxyphenyl)-2-hyyroxyethyl)acetamide Monohydrochloride
53. Acetamide, 2-amino-n-(beta-hydroxy-2,5-dimethoxyphenethyl)-, Hydrochloride
54. Cas-3092-17-9
55. Schembl41463
56. Mls001332567
57. Mls001332568
58. Mls002154233
59. Spectrum1503257
60. St 1085 Hydrochloride
61. Chembl1200461
62. Dtxsid1047493
63. 2-(2-chlorophenoxy)propionicacid
64. Hms1568h03
65. Hms1922o03
66. Pharmakon1600-01503257
67. Midodrine Hydrochloride (jan/usp)
68. Midodrine Hydrochloride [mi]
69. Tox21_110529
70. Tox21_302723
71. Ccg-39323
72. Hy-12749a
73. Mfcd00079455
74. Midodrine Hydrochloride [jan]
75. Nsc758429
76. S5734
77. Akos015895724
78. Tox21_110529_1
79. Cs-4689
80. Hs-0099
81. Midodrine Hydrochloride [mart.]
82. Midodrine Hydrochloride [vandf]
83. Nc00573
84. Nsc 758429
85. Acetamide, 2-amino-n-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)-, Monohydrochloride
86. Midodrine Hydrochloride [usp-rs]
87. Midodrine Hydrochloride [who-dd]
88. Ncgc00095311-01
89. Ncgc00178238-05
90. Ncgc00256810-01
91. Db-047933
92. Ft-0603627
93. Ft-0701302
94. Midodrine Hydrochloride [orange Book]
95. D01307
96. Midodrine Hydrochloride [usp Monograph]
97. 092m179
98. 218m560
99. A820652
100. Q-201404
101. Sr-05000001847-3
102. Q27114696
103. Midodrine Hydrochloride, Analytical Standard, For Drug Analysis
104. Midodrine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
105. (+/-)-2-amino-n-(.beta.-hydroxy-2,5-dimethoxyphenethyl)acetamide Monohydrochloride
106. 2-azanyl-n-[2-(2,5-dimethoxyphenyl)-2-oxidanyl-ethyl]ethanamide Hydrochloride
107. Acetamide, 2-amino-n-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)-, Monohydrochloride, (+/-)-
Molecular Weight | 290.74 g/mol |
---|---|
Molecular Formula | C12H19ClN2O4 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 6 |
Exact Mass | 290.1033348 g/mol |
Monoisotopic Mass | 290.1033348 g/mol |
Topological Polar Surface Area | 93.8 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 263 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Midodrine hydrochloride |
Drug Label | Name: ProAmatine(midodrine hydrochloride) TabletsDosage Form: 2.5-mg, 5-mg and 10-mg tablets for oral administrationActive Ingredient: Midodrine hydrochloride, 2.5 mg, 5 mg and 10 mgInactive Ingredients: Colloidal Silicone Dioxide NF, Corn Starch N... |
Active Ingredient | Midodrine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 2.5mg; 5mg; 10mg |
Market Status | Prescription |
Company | Mylan Pharms; Impax Pharms; Apotex; Sandoz |
2 of 2 | |
---|---|
Drug Name | Midodrine hydrochloride |
Drug Label | Name: ProAmatine(midodrine hydrochloride) TabletsDosage Form: 2.5-mg, 5-mg and 10-mg tablets for oral administrationActive Ingredient: Midodrine hydrochloride, 2.5 mg, 5 mg and 10 mgInactive Ingredients: Colloidal Silicone Dioxide NF, Corn Starch N... |
Active Ingredient | Midodrine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 2.5mg; 5mg; 10mg |
Market Status | Prescription |
Company | Mylan Pharms; Impax Pharms; Apotex; Sandoz |
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Vasoconstrictor Agents
Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)
Adrenergic alpha-1 Receptor Agonists
Compounds that bind to and activate ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Agonists.)
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-11-08
Pay. Date : 2021-09-16
DMF Number : 36272
Submission : 2021-09-21
Status : Active
Type : II
NDC Package Code : 59285-043
Start Marketing Date : 2021-12-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-07-01
Pay. Date : 2014-04-29
DMF Number : 28211
Submission : 2014-04-30
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-03-17
Pay. Date : 2016-09-26
DMF Number : 30806
Submission : 2016-09-27
Status : Active
Type : II
Date of Issue : 2018-12-03
Valid Till : 2021-07-09
Written Confirmation Number : WC-0424
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16481
Submission : 2003-03-24
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-10-29
Pay. Date : 2014-05-12
DMF Number : 16006
Submission : 2002-06-13
Status : Active
Type : II
NDC Package Code : 63190-0080
Start Marketing Date : 2004-11-03
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-01-16
Pay. Date : 2013-09-25
DMF Number : 27464
Submission : 2013-09-18
Status : Active
Type : II
Date of Issue : 2022-06-08
Valid Till : 2025-07-02
Written Confirmation Number : WC-0091
Address of the Firm :
NDC Package Code : 57451-1204
Start Marketing Date : 2013-07-08
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-10-11
Pay. Date : 2018-10-04
DMF Number : 16017
Submission : 2002-06-21
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30216
Submission : 2016-02-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16135
Submission : 2002-09-16
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16481
Submission : 2003-03-24
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18470
Submission : 2005-06-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-10-11
Pay. Date : 2018-10-04
DMF Number : 16017
Submission : 2002-06-21
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-10-29
Pay. Date : 2014-05-12
DMF Number : 16006
Submission : 2002-06-13
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-01-16
Pay. Date : 2013-09-25
DMF Number : 27464
Submission : 2013-09-18
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6315
Submission : 1986-03-10
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-07-01
Pay. Date : 2014-04-29
DMF Number : 28211
Submission : 2014-04-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30216
Submission : 2016-02-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15610
Submission : 2001-09-04
Status : Inactive
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Italy
Brand Name : Gutron
Dosage Form :
Dosage Strength : 30 Cpr Div 2.5 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Midodrina A.
Dosage Form :
Dosage Strength : Gtt Os 30 Ml 0,25 %
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Gutron
Dosage Form :
Dosage Strength : Gtt Os 30 Ml 0.25%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Xerotil
Dosage Form :
Dosage Strength : Gtt Os 30 Ml 0.25%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Gutron
Dosage Form :
Dosage Strength : 6 Ampoules Im 5 Mg 2 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Switzerland
Brand Name : Gutron
Dosage Form : Drops
Dosage Strength : 10mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Switzerland
Brand Name : Gutron
Dosage Form : Drops
Dosage Strength : 10mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Switzerland
Brand Name : Gutron
Dosage Form : Tablet
Dosage Strength : 2.5mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Switzerland
Brand Name : Gutron
Dosage Form : Tablet
Dosage Strength : 2.5mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?